Adsorption of cellular proteins to polyelectrolyte-functionalized gold nanorods: A mechanism for nanoparticle regulation of cell phenotype?

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sisco, Patrick N ^a   Wilson, Christopher G ^b   Chernak, Davin ^a   Clark, Jessica C ^b   Grzincic, Elissa M ^a   Ako Asare, Kayla ^b   Goldsmith, Edie C ^b   Murphy, Catherine J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; NANOROD; POLYELECTROLYTE; TRANSFORMING GROWTH FACTOR BETA; ELECTROLYTE; GOLD; MACROGOL DERIVATIVE; NANOPARTICLE; NANOTUBE; POLY-N,N-DIMETHYL-N,N-DIALLYLAMMONIUM CHLORIDE; POLYETHYLENE DERIVATIVE; PROTEIN; QUATERNARY AMMONIUM DERIVATIVE;

ADSORPTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; ENZYME KINETICS; FIBROBLAST; GEL ELECTROPHORESIS; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NEWBORN; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PROTEIN ANALYSIS; PROTEIN BINDING; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BOVINAE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; ISOLATION AND PURIFICATION; METABOLISM; SPRAGUE DAWLEY RAT; SURFACE PROPERTY;

ADSORPTION; ANIMALS; CATTLE; ELECTROLYTES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLASTS; GENE EXPRESSION REGULATION; GOLD; NANOPARTICLES; NANOTUBES; PHENOTYPE; POLYETHYLENE GLYCOLS; POLYETHYLENES; PROTEINS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES;

EID: 84895529975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086670     Document Type: Article

References (54)

1. Rosi NL, Mirkin CA (2005) Nanostructures in biodiagnostics. Chem Rev 105: 1547-1562. doi:10.1021/cr030067f. (Pubitemid 40596871)
2. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA (2012) The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 41: 2740-2779. doi:10.1039/c1cs15237h.
3. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ (2008) Biological applications of gold nanoparticles. Chem Soc Rev 37: 1896-1908. doi:10.1039/b712170a.
4. Stone JW, Sisco PN, Goldsmith EC, Baxter SC, Murphy CJ (2007) Using Gold Nanorods to Probe Cell-Induced Collagen Deformation. Nano Lett 7: 116-119. doi:10.1021/nl062248d. (Pubitemid 46225838)
5. Wu X, Ming T, Wang X, Wang P, Wang J, et al. (2010) High- photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. ACS Nano 4: 113-120. doi:10.1021/nn901064m.
6. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA (2006) Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 110: 7238-7248. doi:10.1021/jp057170o.
7. Han G, Ghosh P, Rotello VM (2007) Functionalized gold nanoparticles for drug delivery. Nanomedicine (Lond) 2: 113-123. doi:10.2217/17435889.2.1.113. (Pubitemid 46845782)
8. Brown SD, Nativo P, Smith J-A, Stirling D, Edwards PR, et al. (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 132: 4678-4684. doi:10.1021/ja908117a.
9. Jain PK, Huang X, El-Sayed IH, El-Sayed MA (2008) Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine. Acc Chem Res 41: 1578-1586. doi:10.1021/ar7002804.
10. Bardhan R, Lal S, Joshi A, Halas NJ (2011) Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res 44: 936-946. doi:10.1021/ar200023x.
11. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity. Small 1: 325-327. doi:10.1002/smll.200400093. (Pubitemid 43951781)
12. Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Lett 6: 662-668. doi:10.1021/nl052396o.
13. Huff TB, Hansen MN, Zhao Y, Cheng J-X, Wei A (2007) Controlling the cellular uptake of gold nanorods. Langmuir 23: 1596-1599. doi:10.1021/la062642r. (Pubitemid 46406099)
14. Hauck TS, Ghazani AA, Chan WCW (2008) Assessing the Effect of Surface Chemistry on Gold Nanorod Uptake, Toxicity, and Gene Expression in Mammalian Cells. Small 4: 153-159. doi:10.1002/smll.200700217. (Pubitemid 351205749)
15. Alkilany AM, Murphy CJ (2010) Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 12: 2313-2333. doi:10.1007/s11051-010-9911-8.
16. Huang K, Ma H, Liu J, Huo S, Kumar A, et al. (2012) Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 6: 4483-4493. doi:10.1021/nn301282m.
17. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, et al. (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104: 2050-2055. doi:10.1073/pnas.0608582104. (Pubitemid 46391350)
18. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, et al. (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proceedings of the National Academy of Sciences 105: 14265-14270. doi:10.1073/pnas.0805135105.
19. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4: 3623-3632. doi:10.1021/nn901372t.
20. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA (2010) What the cell "sees" in bionanoscience. J Am Chem Soc 132: 5761-5768. doi:10.1021/ja910675v.
21. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, et al. (2011) Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133: 2525-2534. doi:10.1021/ja107583h.
22. Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, et al. (2011) The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5: 7503-7509. doi:10.1021/nn202458g.
23. Xia XR, Monteiro-Riviere NA, Mathur S, Song X, Xiao L, et al. (2011) Mapping the surface adsorption forces of nanomaterials in biological systems. ACS Nano 5: 9074-9081. doi:10.1021/nn203303c.
24. Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, et al. (2010) Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4: 7481-7491. doi:10.1021/nn101557e.
25. Sund J, Alenius H, Vippola M, Savolainen K, Puustinen A (2011) Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. ACS Nano 5: 4300-4309. doi:10.1021/nn101492k.
26. Lartigue L, Wilhelm C, Servais J, Factor C, Dencausse A, et al. (2012) Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano 6: 2665-2678. doi:10.1021/nn300060u.
27. Comfort KK, Maurer EI, Braydich-Stolle LK, Hussain SM (2011) Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano 5: 10000-10008. doi:10.1021/ nn203785a.
28. Sisco PN, Wilson CG, Mironova E, Baxter SC, Murphy CJ, et al. (2008) The effect of gold nanorods on cell-mediated collagen remodeling. Nano Lett 8: 3409-3412. doi:10.1021/nl802142h.
29. Wilson CG, Sisco PN, Gadala-Maria FA, Murphy CJ, Goldsmith EC (2009) Polyelectrolyte-coated gold nanorods and their interactions with type I collagen. Biomaterials 30: 5639-5648. doi:10.1016/j.biomaterials.2009.07.011.
30. Wilson CG, Sisco PN, Goldsmith EC, Murphy CJ (2009) Glycosaminoglycan- functionalized gold nanorods: interactions with cardiac cells and type I collagen. J Mater Chem 19: 6332-6340.
31. Shaw CP, Middleton DA, Volk M, Lévy R (2012) Amyloid-derived peptide forms self-assembled monolayers on gold nanoparticle with a curvature-dependent β-sheet structure. ACS Nano 6: 1416-1426. doi:10.1021/nn204214x.
32. Jana NR, Gearheart L, Murphy CJ (2001) Wet Chemical Synthesis of High Aspect Ratio Cylindrical Gold Nanorods. J Phys Chem B 105: 4065-4067. doi:10.1021/jp0107964. (Pubitemid 35381537)
33. Gole A, Murphy CJ (2005) Polyelectrolyte-Coated Gold Nanorods: Synthesis, Characterization and Immobilization. Chem Mater 17: 1325-1330. doi:10.1021/cm048297d. (Pubitemid 40395700)
34. Mrksich M, Whitesides GM (1996) Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells. Annu Rev Biophys Biomol Struct 25: 55-78. doi:10.1146/annurev.bb.25.060196.000415.
35. Faucheux N, Schweiss R, Lützow K, Werner C, Groth T (2004) Self-assembled monolayers with different terminating groups as model substrates for cell adhesion studies. Biomaterials 25: 2721-2730. doi:10.1016/j. biomaterials.2003.09.069. (Pubitemid 38202319)
36. Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, et al. (2000) "Stealth" corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids and Surfaces B: Biointerfaces 18: 301-313. (Pubitemid 30479870)
37. Dobrovolskaia MA, McNeil SE (2007) Immunological properties of engineered nanomaterials. Nature Nanotechnology 2: 469-478. doi:10.1038/nnano.2007.223. (Pubitemid 47220069)
38. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, et al. (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8: 543-557. doi:10.1038/nmat2442.
39. Walkey CD, Chan WCW (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41: 2780-2799. doi:10.1039/c1cs15233e.
40. Iozzo RV (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32: 141-174. doi:10.3109/10409239709108551.
41. Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, et al. (2008) Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 117: 1269-1276. doi:10.1161/CIRCULATIONAHA.107.714147. (Pubitemid 351365659)
42. Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, et al. (2012) Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br J Cancer 106: 1214-1223. doi:10.1038/bjc.2012.59.
43. Melchior-Becker A, Dai G, Ding Z, Schäfer L, Schrader J, et al. (2011) Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem 286: 17365-17375. doi:10.1074/jbc.M110. 192682.
44. Brown RD, Ambler SK, Mitchell MD, Long CS (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45: 657-687. doi:10.1146/annurev.pharmtox.45.120403.095802. (Pubitemid 40261821)
45. Hong R, Fischer NO, Verma A, Goodman CM, Emrick T, et al. (2004) Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. J Am Chem Soc 126: 739-743. doi:10.1021/ja037470o. (Pubitemid 38114356)
46. Lundqvist M, Nygren P, Jonsson B-H, Broo K (2006) Induction of structure and function in a designed peptide upon adsorption on a silica nanoparticle. Angew Chem Int Ed Engl 45: 8169-8173. doi:10.1002/anie.200600965. (Pubitemid 44974154)
47. Roach P, Farrar D, Perry CC (2006) Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J Am Chem Soc 128: 3939-3945. doi:10.1021/ja056278e.
48. Shang W, Nuffer JH, Dordick JS, Siegel RW (2007) Unfolding of ribonuclease A on silica nanoparticle surfaces. Nano Lett 7: 1991-1995. doi:10.1021/nl070777r. (Pubitemid 47197579)
49. Asuri P, Karajanagi SS, Vertegel AA, Dordick JS, Kane RS (2007) Enhanced stability of enzymes adsorbed onto nanoparticles. J Nanosci Nanotechnol 7: 1675-1678.
50. Mandal HS, Kraatz H-B (2007) Effect of the surface curvature on the secondary structure of peptides adsorbed on nanoparticles. J Am Chem Soc 129: 6356-6357. doi:10.1021/ja0703372. (Pubitemid 46799316)
51. Gole A, Murphy CJ (2008) Azide-derivatized gold nanorods: functional materials for "click" chemistry. Langmuir 24: 266-272. doi:10.1021/la7026303.
52. Borg TK, Rubin K, Lundgren E, Borg K, Obrink B (1984) Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Dev Biol 104: 86-98. PMID: 6734942.
53. Sasisekharan R, Ernst S, Venkataraman G. (1997) On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis 1: 45-54. PMID: 14517393. (Pubitemid 127505701)
54. Ramos C, Montano M, Becerril C, Cisneros-Lira J, Barrera L, Ruiz V, Pardo A, Selman M. (2006) Acidic fibroblast growth factor decreases a-smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 291: L871-879. PMID: 16766579. (Pubitemid 44772048)